Bruker Corp (BRKR)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Ticker
BRKR
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical Devices
Market cap
$9.36B
52-week range
$32.37 - $68.98

Valuation

Share price
$61.31 (close of Nov 6, 2026)
P/E (TTM)
-55.74x
Price to book
4.06x
Price to free cash flow
38.26x
Enterprise value
$10.96B
Book value per share
$15.10

Price performance

PeriodChange
1 day+5.60%
5 days+7.43%
1 month+1.34%
3 months+19.58%
6 months+44.94%
Year to date+30.14%
1 year+55.97%
3 years+9.19%
5 years-24.91%
10 years+178.56%
All time+165.84%

Short interest

As of
Oct 15, 2026
Short % of float
16.03%
Shares short
12.67M
Days to cover
5.71
Change since prior report
+2.15%
Source
FINRA consolidated short interest

Profitability and growth

Return on equity
-0.35%
Return on invested capital
0.86%
Return on assets
-0.14%
Return on capital employed
1.37%
Gross margin
45.91%
Net margin
-0.25%
EBITDA margin
8.40%
Revenue growth
2.08%
Net income growth
-107.60%
Free cash flow growth
-68.16%

Cash flow and balance sheet

Free cash flow yield (TTM)
2.61%
Current ratio
1.84x
Net debt to EBITDA
6.99x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$3.44B
Cost of revenue
$1.86B
Gross profit
$1.58B
EBITDA
$288.50M
Net income
-$8.60M
Earnings per share
$-0.15
Research and development
$395.20M
Interest expense
$60.30M
Shares outstanding
151.80M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-12-31$3.44B$1.58B-$8.60M-$0.15
2024-12-31$3.37B$1.65B$113.10M$0.76
2023-12-31$2.96B$1.51B$427.20M$2.92
2022-12-31$2.53B$1.31B$296.60M$2.00
2021-12-31$2.42B$1.21B$277.10M$1.83
2020-12-31$1.99B$939.80M$157.80M$1.03
2019-12-31$2.07B$995.30M$197.20M$1.27
2018-12-31$1.90B$900.00M$179.70M$1.15
2017-12-31$1.77B$816.00M$78.60M$0.50
2016-12-31$1.61B$745.30M$153.60M$0.95

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-12-3145.91%-0.25%-0.35%0.86%
2024-12-3149.00%3.36%6.29%4.00%
2023-12-3151.05%14.41%30.63%11.51%
2022-12-3151.59%11.72%26.35%13.20%
2021-12-3150.03%11.46%25.55%12.12%
2020-12-3147.29%7.94%16.20%9.75%
2019-12-3148.02%9.51%21.50%12.15%
2018-12-3147.48%9.48%19.85%15.94%
2017-12-3146.21%4.45%10.72%9.55%
2016-12-3146.25%9.53%22.16%14.36%

Cash and debt by year

Period endCashDebt
2025-12-31$298.80M$1.85B
2024-12-31$183.40M$2.06B
2023-12-31$488.30M$1.16B
2022-12-31$645.50M$1.20B
2021-12-31$1.17B$1.22B
2020-12-31$731.80M$842.30M
2019-12-31$684.90M$812.80M
2018-12-31$322.40M$322.60M
2017-12-31$439.20M$415.60M
2016-12-31$500.30M$391.60M

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$43.30M$20.20M
2024-12-31$136.00M$25.30M
2023-12-31$243.20M$30.90M
2022-12-31$145.20M$27.70M
2021-12-31$190.40M$17.20M
2020-12-31$235.00M$16.00M
2019-12-31$140.40M$9.60M
2018-12-31$190.50M$11.30M
2017-12-31$110.70M$11.00M
2016-12-31$93.70M$9.40M

Dividend history

Most recent payment
Sep 21, 2026
Paid in the last twelve months
$0.20
Payment dateDividend per share
2026-09-21$0.05
2026-06-22$0.05
2026-03-23$0.05
2025-12-08$0.05
2025-09-23$0.05
2025-06-16$0.05
2025-03-17$0.05
2024-12-02$0.05

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-04Sep 2026$0.42
2026-08-04Jun 2026$0.38
2026-05-06Mar 2026$0.23
2026-02-12Dec 2025$0.65
2025-11-03Sep 2025$0.33
2025-08-04Jun 2025$0.33
2025-05-07Mar 2025$0.46
2025-02-13Dec 2024$0.75

Filings and sources

Company website
bruker.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · Boston Scientific Corp (BSX) · Edwards Lifesciences Corp (EW) · GE HealthCare Technologies Inc. (GEHC) · Dexcom Inc (DXCM) · STERIS plc (STE)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades